Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With Advanced or Metastatic Colorectal Cancer That Has Been Previously Treated

clinical trial

Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With Advanced or Metastatic Colorectal Cancer That Has Been Previously Treated is …
instance of (P31):
clinical trialQ30612

External links are
P3098ClinicalTrials.gov IDNCT00025337

P6099clinical trial phasephase III clinical trialQ42824827
P17countryUnited States of AmericaQ30
P582end time2007-04-01
P1050medical conditionadenocarcinomaQ356033
P2899minimum age18
P1132number of participants880
P4844research interventioncalcium oxalateQ412399
bevacizumabQ413299
fluorouracilQ238512
leucovorin calciumQ27077063
immunological antineoplastic agentQ50429626
P6153research siteEastern Cooperative Oncology GroupQ5330089
P580start time2001-09-01
P8363study typeinterventional studyQ78089383
P1476titlePhase III Trial of Bevacizumab (NSC 704865), Oxaliplatin (NSC 266046), Fluorouracil and Leucovorin Versus Oxaliplatin, Fluorouracil and Leucovorin Versus Bevacizumab Alone in Previously Treated Patients With Advanced Colorectal Cancer

Search more.